No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Ponatinib with FLAG-IDA is a feasible and active treatment strategy in patients with blast-phase chronic myeloid leukaemia

MATCHPOINT trial

byKathleen Lau

June 12, 2022

in StudyGraphics

Reading Time: 1 min read

RELATED REPORTS

Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study

Punjab launches AI screening program this week

2MM: AI Roundup –Lilly launches TuneLab AI drug discovery, smart wound healing bandage, and Punjab cancer screening [September 25th, 2025]

#VisualAbstract: Only one quarter of benzodiazepine prescriptions in youth are for approved indication

RelatedReports

Evidence-based interventions for pediatric asthma successfully adapted for community health centers

Chronic Disease

Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study

October 13, 2025

Blindness and visual impairment decreasing worldwide

AI Roundup

Punjab launches AI screening program this week

September 30, 2025

AI Roundup

2MM: AI Roundup –Lilly launches TuneLab AI drug discovery, smart wound healing bandage, and Punjab cancer screening [September 25th, 2025]

September 28, 2025

Variation noted across pre- and post-marketing studies for FDA approved devices

AI Roundup

Artificial intelligence accelerates drug discovery and reduces animal testing

September 12, 2025

Long-term outcomes for off-pump and on-pump CABG are similar

2 Minute Medicine Rewind June 13, 2022

Multiple variables related to physical activity levels in preschool children

Blended physical literacy interventions may improve physical literacy in children

Neoadjuvant dostarlimab is a promising treatment option in locally advanced dMMR rectal cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result